Back
Citius Oncology Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
7
CTOR
Citius Oncology
Last Price:
$1.60
Seasonality Move:
-44.29%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CTOR is experiencing slight selling pressure.
Citius Oncology Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 3.05 | Sell |
20-day SMA: | 3.3 | Sell |
50-day SMA: | 1.92 | Sell |
200-day SMA: | 1.26 | Buy |
8-day EMA: | 2.68 | Sell |
20-day EMA: | 2.91 | Sell |
50-day EMA: | 2.26 | Sell |
200-day EMA: | 2.61 | Sell |
Citius Oncology Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.14 | Buy |
Relative Strength Index (14 RSI): | 36.8 | Sell |
Chaikin Money Flow: | -1033549 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.53 - 4.31) | Sell |
Bollinger Bands (100): | (0.21 - 2.51) | Buy |
Citius Oncology Technical Analysis
Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Citius Oncology Stock
Is Citius Oncology Stock a Buy?
-
Citius Oncology share price is 1.57 while CTOR 8-day simple moving average is 3.05, which is a Sell signal.
-
The stock price of CTOR is 1.57 while Citius Oncology 20-day SMA is 3.30, which makes it a Sell.
-
Citius Oncology 50-day simple moving average is 1.92 while CTOR share price is 1.57, making it a Sell technically.
-
CTOR stock price is 1.57 and Citius Oncology 200-day simple moving average is 1.26, creating a Buy signal.
CTOR Technical Analysis vs Fundamental Analysis
Sell
7
Citius Oncology (CTOR)
is a Sell
Is Citius Oncology a Buy or a Sell?
-
Citius Oncology stock is rated a SellThe current Citius Oncology [CTOR] share price is $1.57. The Score for CTOR is 7, which is 86% below its historic median score of 50, and infers higher risk than normal.
Citius Oncology Stock Info
Market Cap:
112.3M
Price in USD:
1.57
Share Volume:
16.2M
Citius Oncology 52-Week Range
52-Week High:
49.00
52-Week Low:
0.55
Sell
7
Citius Oncology (CTOR)
is a Sell
Citius Oncology Share Price Forecast
-
What is the Citius Oncology stock price today?The Citius Oncology stock price is 1.57 USD today.
-
Will CTOR stock go up or go down?Citius Oncology> share price is forecast to RISE/FALL based on technical indicators
-
Is Citius Oncology overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Citius Oncology is overvalued.
Is Citius Oncology Stock a Buy?
-
Citius Oncology share price is 1.57 while CTOR 8-day exponential moving average is 2.68, which is a Sell signal.
-
The stock price of CTOR is 1.57 while Citius Oncology 20-day EMA is 2.91, which makes it a Sell.
-
Citius Oncology 50-day exponential moving average is 2.26 while CTOR share price is 1.57, making it a Sell technically.
-
CTOR stock price is 1.57 and Citius Oncology 200-day simple moving average is 2.61, creating a Sell signal.
Technical Analysis of Citius Oncology
Should I short Citius Oncology stock?
-
CTOR Moving Average Covergence Divergence (MACD) indicator is 0.14, suggesting Citius Oncology is a Buy
-
Citius Oncology Relative Strength Index (RSI) is 36.8, which suggest Citius Oncology is oversold
-
The Bollinger Bands (25) for Citius Oncology is (1.53 - 4.31), which suggest Citius Oncology is a Buy
-
The Bollinger Bands (100) for Citius Oncology is (0.21 - 2.51), which suggest Citius Oncology is a Buy
* Citius Oncology stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.